Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study
- PMID: 35151257
- PMCID: PMC8840680
- DOI: 10.1186/s12877-022-02782-5
Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study
Abstract
Background: The reduced renal function has prognostic significance in COVID-19 and it has been linked to mortality in the general population. Reduced renal function is prevalent in older age and thus we set out to better understand its effect on mortality.
Methods: Patient clinical and demographic data was taken from the COVID-19 in Older People (COPE) study during two periods (February-June 2020 and October 2020-March 2021, respectively). Kidney function on admission was measured using estimated glomerular filtration rate (eGFR). The primary outcomes were time to mortality and 28-day mortality. Secondary outcome was length of hospital stay. Data were analysed with multilevel Cox proportional hazards regression, and multilevel logistic regression and adjusted for individual patient clinical and demographic characteristics.
Results: One thousand eight hundred two patients (55.0% male; median [IQR] 80 [73-86] years) were included in the study. 28-day mortality was 42.3% (n = 742). 48% (n = 801) had evidence of renal impairment on admission. Using a time-to-event analysis, reduced renal function was associated with increased in-hospital mortality (compared to eGFR ≥ 60 [Stage 1&2]): eGFR 45-59 [Stage 3a] aHR = 1.26 (95%CI 1.02-1.55); eGFR 30-44 [Stage 3b] aHR = 1.41 (95%CI 1.14-1.73); eGFR 1-29 [Stage 4&5] aHR = 1.42 (95%CI 1.13-1.80). In the co-primary outcome of 28-day mortality, mortality was associated with: Stage 3a adjusted odds ratio (aOR) = 1.18 (95%CI 0.88-1.58), Stage 3b aOR = 1.40 (95%CI 1.03-1.89); and Stage 4&5 aOR = 1.65 (95%CI 1.16-2.35).
Conclusion: eGFR on admission is a good independent predictor of mortality in hospitalised older patients with COVID-19 population. We found evidence of a dose-response between reduced renal function and increased mortality.
Keywords: COVID-19; Chronic kidney failure; Dose-response; Mortality; eGFR.
© 2022. The Author(s).
Conflict of interest statement
EAR received the Gwyn Seymour Scholarship from the Department of Medicine for the Elderly, NHS Grampian, as part of the Aberdeen Summer Research Scholarship Scheme, Aberdeen Clinical Academic Training Programme, University of Aberdeen. The remaining authors declare no competing interests.
Figures
Similar articles
-
Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study.Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii170-ii179. doi: 10.1093/ndt/gfw457. Nephrol Dial Transplant. 2017. PMID: 28339801
-
Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19.BMC Infect Dis. 2024 May 25;24(1):527. doi: 10.1186/s12879-024-09414-w. BMC Infect Dis. 2024. PMID: 38796423 Free PMC article.
-
Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.Ann Med. 2024 Dec;56(1):2361843. doi: 10.1080/07853890.2024.2361843. Epub 2024 Jun 3. Ann Med. 2024. PMID: 38830017 Free PMC article.
-
Increased Estimated GFR Is Negatively Associated With the Risk of SARS-CoV-2 Infection and Severe COVID-19 Within Normal to Mildly Decreased Levels: Nested Case-Control Study.J Korean Med Sci. 2023 Dec 18;38(49):e415. doi: 10.3346/jkms.2023.38.e415. J Korean Med Sci. 2023. PMID: 38111284 Free PMC article.
-
Increased vulnerability to COVID-19 in chronic kidney disease.J Intern Med. 2021 Jul;290(1):166-178. doi: 10.1111/joim.13239. Epub 2021 Feb 10. J Intern Med. 2021. PMID: 33452733 Free PMC article.
Cited by
-
Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study).Biomed Pharmacother. 2022 Sep;153:113454. doi: 10.1016/j.biopha.2022.113454. Epub 2022 Jul 21. Biomed Pharmacother. 2022. PMID: 36076568 Free PMC article.
-
Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study.Clin Kidney J. 2023 Nov 28;17(1):sfad283. doi: 10.1093/ckj/sfad283. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186903 Free PMC article.
-
The relevance of geriatric assessments on the association between chronic kidney disease stages and mortality among older people: a secondary analysis of a multicentre cohort study.Age Ageing. 2022 Jul 1;51(7):afac168. doi: 10.1093/ageing/afac168. Age Ageing. 2022. PMID: 35871417 Free PMC article.
-
The prognostic value of estimated glomerular filtration rate on admission for death within 30 days among COVID-19 inpatients using fractional polynomial and spline smoothing.Int Urol Nephrol. 2023 Oct;55(10):2657-2666. doi: 10.1007/s11255-023-03575-4. Epub 2023 Mar 29. Int Urol Nephrol. 2023. PMID: 36988864 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous